RNXT
RenovoRx Inc
1.60$
-0.6%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | -33.3% | -100.0% | – | – | |
| – | +31.6% | +194.0% | +338.1% | +67.4% | +8.9% | +7.9% | |
| – | +8.7% | -166.0% | – | – | – | – | |
| – | -160.7% | – | – | +41.4% | -53.7% | -188.2% | |
| – | +0.0% | +0.0% | -100.0% | – | – | -83.3% | |
| – | +1,400.0% | +0.0% | +13,446.7% | – | -100.6% | -83.3% | |
| – | +0.0% | -37.8% | -100.0% | – | – | – | |
| – | +0.0% | +504.2% | -99.8% | +11,823.8% | +201.9% | -28.3% | |
| – | – | – | -180.6% | – | – | -102.2% | |
| – | – | – | – | – | – | – |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.